Sales of weight loss pill sibutramine unlikely to be banned

Published: 2010-03-03 06:58:00
Updated: 2010-03-03 06:58:00
The controversial anti-obesity drug sibutramine will not be banned in Korea, reports said.

In a recent forum, the Korea Food and Drug Administration Director Yoo Moo-young said that the drug agency’s review showed the higher heart risks extended only to patients with a history of cardiovascula...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.